| |
|
|
|
|
|
|
|||
|
REVIEW ARTICLE
From the Department of Cancer Biology and Biochemistry
and the Comprehensive Cancer Center, Wake Forest University School of
Medicine, Winston-Salem, NC.
Increasingly, perturbations in cellular iron and ferritin are
emerging as an important element in the pathogenesis of disease. These
changes in ferritin are important not only in the classic diseases of
iron acquisition, transport, and storage, such as primary
hemochromatosis, but also in diseases characterized by inflammation,
infection, injury, and repair. Among these are some of the most common
diseases that afflict mankind: neurodegenerative diseases such as
Parkinson disease1 and Alzheimer disease,2 vascular diseases such as cardiac and neuronal ischemia-reperfusion injury,3,4 atherosclerosis itself,5 pulmonary
inflammatory states,6 rheumatoid
arthritis,7,8 and a variety of premalignant conditions and
frank cancers.9 We are just beginning to learn the
mechanisms and implications of alterations in ferritin and iron
homeostasis from these natural "experiments." However, what is
increasingly apparent is that ferritin appears to be a key molecule
that limits the extent, character, and location of the pro-oxidant
stress that typifies inflammatory diseases, cancer, and conditions of
altered oxygenation. The link between alteration in ferritin regulation
and these diseases is forged through a diverse set of cellular stress
pathways that alter ferritin subunit composition and/or content within
cells. The 2 broad themes developed in this review are that
understanding the signals and pathways that regulate ferritin may lead
to insights into the pathophysiology of these diseases, and that
attention to how ferritin responds to stress will in turn teach us more
about the normal functions of this complex protein. Ferritin is a ubiquitous and highly conserved
iron-binding protein. In vertebrates, the cytosolic form consists of 2 subunits, termed H and L. Twenty-four ferritin subunits assemble to
form the apoferritin shell. Each apoferritin molecule of 450 000 d can
sequester up to approximately 4500 iron atoms.10 Depending on the tissue type and physiologic status of the cell, the ratio of H
to L subunits in ferritin can vary widely, from predominantly L in such
tissues as liver and spleen, to predominantly H in heart and
kidney.11 The H-to-L ratio is not fixed, but is rather
quite plastic: it is readily modified in many inflammatory and
infectious conditions, and in response to xenobiotic stress,
differentiation, and developmental transitions, as well as other
stimuli. Ferritin H and L subunits are encoded by separate
genes.12,13 Although a single functional H and L gene was
thought to be expressed in all vertebrate species, a functional
mitochondrial ferritin gene has recently been described.14
Multiple pseudogenes are also present.15-17 Ferritin also
has enzymatic properties, converting Fe(II) to Fe(III) as iron is
internalized and sequestered in the ferritin mineral core. Use
of recombinant ferritins has demonstrated that this function is
an inherent feature of the H subunit of ferritin, which has a
ferroxidase activity.18 The ferroxidase center is
evolutionarily conserved,10 and ferroxidase activity is
dramatically reduced following mutation of residues His65 and Glu62 in
both human and mouse.18,19
Small quantities of ferritin are also present in human serum, and are
elevated in conditions of iron overload and
inflammation.20-22 Serum ferritin is iron-poor, resembles
ferritin L immunologically, and may contain a novel "G"
(glycosylated) subunit.23 Despite widespread use of serum
ferritin as a clinical indicator of body iron stores, little is known
of the source of this ferritin. However, the increase in serum ferritin
in patients with mutations in ferritin L has led to the suggestion that
serum ferritin and ferritin L derive from the same gene
product24 (see below).
The critical role of ferritin in cellular and organismal iron
homeostasis is intimately linked to its primary and best-studied function Recently, it has become evident that regulatory factors, in
addition to those that regulate iron flux, have an important impact on
cellular ferritin (Table 1). In fact,
ferritin can be viewed not only as part of a group of iron regulatory
proteins that include transferrin and the transferrin receptor, but
also as a member of the protein family that orchestrates the cellular
defense against stress and inflammation.33 This review
focuses on the molecular mechanisms and biologic implications of
ferritin regulation by cytokines, oxidants, oncogenes, growth factors,
and other stimuli, as well as their relevance to the complex and
still poorly understood events that perturb ferritin and iron
homeostasis in a number of disease states.
Not only does ferritin sequester iron in a nontoxic form, but
levels of "labile" iron regulate cellular ferritin levels,
protecting cells from damage triggered by excess iron. Iron-mediated,
largely posttranscriptional pathways of ferritin regulation have been identified through a series of elegant experiments over the last 15 years.34-42 The events that coordinate ferritin
regulation are described briefly below and are illustrated in Figure
1. The reader is also referred to
detailed reviews of this subject.38,43 Although
there is widespread agreement that these regulatory mechanisms are
utilized in many cell types, additional regulatory pathways may be
operant in erythroid cells, due to the specialized function of these
cells in hemoglobin synthesis.44
The content of cytoplasmic ferritin is regulated by the translation of ferritin H and L mRNAs in response to an intracellular pool of "chelatable" or "labile" iron.45,46 Thus, when iron levels are low, ferritin synthesis is decreased; conversely, when iron levels are high, ferritin synthesis increases. Although in certain circumstances there is an increase in ferritin mRNA in response to iron,47 the regulatory response of ferritin to iron is largely posttranscriptional,48 and is due to the recruitment of stored mRNA from monosomes to polysomes in the presence of iron.46 This process is mediated by interaction between RNA binding proteins and a region in the 5' untranslated region of ferritin H and L mRNA termed the iron responsive element (IRE) that has a "stem-loop" secondary structure. There are 2 RNA binding proteins, iron regulatory proteins 1 and 2 (IRP1 and IRP2), that bind to this stem loop structure and inhibit mRNA translation. However, the proteins are regulated differently: IRP1 is an iron-sulfur cluster protein that exists in 2 forms. When iron is abundant, it exists as a cytosolic aconitase. When iron is scarce, it assumes an open configuration associated with the loss of iron atoms in the iron-sulfur cluster, and can bind the IRE stem loop, acting as a repressor of ferritin translation. In contrast, IRP2 is regulated by degradation: IRP2 protein is abundant in iron scarcity, but is degraded rapidly in iron excess through targeting of a unique 73 amino acid sequence.49 Although both IRP1 and IRP2 bind the IRE and exert an inhibitory effect on ferritin synthesis, there is evidence that IRP1 and IRP2 may have distinct tissue-specific roles.50-52 Thus, IRP2 knockout mice exhibit a pronounced misregulation of iron metabolism in the intestinal mucosa and central nervous system,53 suggesting that the function of IRP2 in these tissues cannot be complemented by IRP1. Further, relative ratios of IRP1/IRP2 differ in a tissue-specific fashion, with IRP1 being more abundant than IRP2 in liver, kidney, intestine, and brain, and less abundant in pituitary and a pro-B-lymphocytic cell line.51 Action of IRP proteins can be further modulated through the activation of signal transduction cascades. For example, activation of protein kinase C (PKC) by phorbol esters phosphorylates IRP1 and increases its binding to the IRE.54 Similarly, PKC can activate IRP2, but through phosphorylation of different serine residues.54 Recently, a protein distinct from IRP1 and IRP2 that binds to a 5' stem loop structure of mitochondrial complex 1 has been identified.55 Perhaps the most interesting feature of the IRE-IRP interaction is the conservation of the IRE sequence in other genes that regulate iron homeostasis. For example, the 3' untranslated region (UTR) of the transferrin receptor gene contains 5 tandem IRE sequences. IRE-IRP binding lengthens transferrin receptor mRNA half-life, ultimately leading to increased transferrin receptor display on the cell surface in situations of iron depletion. Thus, similar RNA-protein binding motifs can have strikingly different biologic effects when located in different positions on different genes. In the case of ferritin, IRP binding results in inhibition of translation, whereas in the transferrin receptor, IRP binding increases transferrin receptor mRNA half-life.56 In addition to ferritin H and L and transferrin receptor, inducible eALA synthase (the enzyme catalyzing the rate-limiting step in heme biosynthesis), mitochondrial aconitase, and DMT-1 (the recently discovered divalent metal transporter, also termed DCT-1 and Nramp2), have functional IRE sequences.57 IRE sequences have been identified in a number of other genes including ferroportin1/IREG1/MTP127,58,59; however, whether they function in IRP binding has not yet been determined.
Before one can approach the regulation of ferritin by signals other than cellular iron, it is essential to have an understanding of the overall gene structure of ferritin. This topic, as well as ferritin protein structure, has been extensively reviewed, and the reader is referred to excellent and detailed reviews of the protein, its crystal structure, and the implications for iron catalysis and storage.10,60,61 The structure of ferritin genes and proteins are highly conserved,
likely due to the critical role of ferritin in the maintenance of iron
homeostasis in species ranging from plants to humans. In vertebrates,
the structure of cytoplasmic ferritin genes in all species studied thus
far shows 3 introns and 4 exons, with the intron-exon boundaries
occurring at similar locations.62 Sequences that code for
a stem loop structure The importance of the IRE in ferritin regulation is highlighted by the
discovery of an autosomal dominant disorder resulting in
hyperferritinaemia and cataracts, which can be attributed to point
mutations in the IRE of ferritin L mRNA, leading to the constitutive
activation of ferritin L translation and high serum ferritin in the
absence of iron excess (Table 2). A
recently discovered autosomal dominant mutation in the IRE of ferritin H leads to increased affinity of the IRE for IRP, reduced ferritin H
protein, and iron overload.63 A dominantly inherited
mutation in the C-terminal domain of ferritin L with an associated
decrease in serum ferritin and abnormal deposition of ferritin and iron in the brain has also been described: this mutation has been suggested to underlie a new syndrome termed
"neuroferritinopathy."64
In nonvertebrate animals and plants, structural analysis and functional studies in many species have either failed to reveal structures compatible with posttranscriptional regulation by iron, or have revealed sequences that are not functional IRP binding sites. Instead, transcriptional regulation of ferritin is most frequently (although not universally) identified as a primary mode of response to exogenous iron as well as stress-related signals.65-72
The cytokine tumor necrosis factor alpha (TNF TNF
The regulatory elements in the murine gene that respond to cytokines
have been mapped in detail, and the DNA binding proteins that mediate
this response have been identified (Figure 2). Ferritin H is regulated
by TNF Cytokines also have transcriptional effects on ferritin in other cell
types. Ferritin induction in macrophages may be particularly important,
given their central role in iron homeostasis as scavengers of old and
damaged red blood cells, a critical and quantitatively important
element in whole body iron turnover. In the U937 macrophage cell line,
the proinflammatory cytokines TNF Cytokines also regulate ferritin posttranscriptionally. Early
experimental models involving induction of inflammation in rats with
turpentine demonstrated increased ferritin synthesis in the liver84; an increase in ferritin synthesis but not
ferritin mRNA was also seen in liver slices from turpentine-treated
rats.85 A subsequent study revealed an increase in
ferritin mRNA in the livers of turpentine-treated rats; in this series
of experiments, concomitant nitric oxide (NO)-mediated
induction of IRP activity prevented a coordinate increase in ferritin
protein (see below).86 The response of ferritin in
cultured hepatocytes treated with defined cytokines has also been
investigated. In the HepG2 hepatic cell line, induction of ferritin
synthesis was observed with a number of cytokines: IL-1 Cytokines may also affect ferritin translation indirectly through their ability to induce iNOS (nitric oxide synthase) and hence increase NO.50,91,92 NO in turn causes the activation of both IRP1 and IRP2 (although effects on IRP2 appear to exhibit some cell type specificity), effects that may be particularly important in inflammatory conditions. Mechanisms hypothesized to underlie NO-mediated induction of IRP binding activity include cluster disassembly (IRP1), intracellular iron chelation (IRP1 and IRP2), or increased de novo synthesis (IRP2).93 Secretion of ferritin is stimulated by cytokines. In primary cultured
human hepatocytes, IL-1 Cytokines play a pivotal role in the cellular response to infection, and ferritin plays a prominent role in the cytokine response. Lipopolysaccharide (LPS; endotoxin), a component of the outer membrane of gram-negative bacteria, elicits a variety of reactions that involve ferritin. Although stimulation of a number of inflammatory cytokines is associated with LPS, the cellular reaction is complex, and in animals can involve vascular leak syndrome, the coagulation cascade, activation of complement, and prostaglandin synthesis. LPS administered endotracheally to rats induced ferritin protein but not mRNA.96 Similarly, tail vein injection of rats with LPS increased immunoreactive ferritin in the spleen.97 Viral infection with mengo picornavirus has been reported to lead to an increase in ferritin.98 Cyclopentenone prostaglandins (A-type prostaglandins A1, A2, J2, etc), which are involved in inflammatory and febrile responses as well as viral replication, induced L chain ferritin, heme oxygenase, and HSP 70 in human monocytes.99 Ferritin is also involved in the inflammatory processes of
atherosclerosis. In a study to determine the genes regulated in atherogenesis, cDNA libraries were constructed from atherosclerotic aorta and screened for genes differentially expressed in normal and
atherosclerotic plaques.5 Ferritin H and L mRNAs were
markedly induced in the aortas of rabbits fed an atherogenic diet for 6 weeks. In situ hybridization revealed that both H and L ferritin were
induced in endothelial cells and in macrophages. Cells in culture were
then used to model elements of the atherosclerotic process. In the
THP-1 monocytic cell line and in aortic smooth muscle, ferritin was
up-regulated by IL-1 and TNF
Transcription of the human ferritin H gene is induced in response to both hormones and second messengers, including cAMP. The cis-acting elements mediating these responses have mapped to a relatively small region in the proximal promoter of the human ferritin H gene (Figure 2). There were 2 groups that identified ferritin H as a gene differentially expressed in response to thyrotropin in rodent cells.100,101 Subsequent work revealed that dibutyryl-cAMP recapitulated the effect of thyrotropin on ferritin H transcripts, albeit with different kinetics.102 Short fragments of the rat 5' flanking region (up to 400 bp) but not longer fragments were responsive to dibutyryl-cAMP and thyrotropin in murine 3T3 cells and FRTL5 thyroid cells.103,104 Nuclear run-on assays confirmed the transcriptional effect of thyrotropin on ferritin H.105 The cAMP-dependent induction of ferritin was inhibited by ras in a rat thyroid cell line.106 Collectively, these experiments demonstrated that thyrotropin increased
ferritin H transcription, probably by elevating cAMP. cAMP-mediated
induction of ferritin H transcription was further defined in human HeLa
cells.107 The human cAMP-responsive region (the B-box)
binds a protein complex termed B-box binding factors (Bbf), comprised
of the transcription factor NFY, the coactivator p300, and the histone
acetylase p300/CBP associated factor
(PCAF).108,109 The adenoviral oncogene E1A
reduces the formation of this complex. Overexpression of p300 in HeLa
cells reverses the E1A-mediated inhibition of the ferritin promoter
driven by Bbf.110 Okadaic acid, a phosphatase inhibitor,
stimulates H ferritin transcription in HeLa cells by increasing the
interaction between the p300 coactivator molecule and other components
of Bbf.111 In cells with low expression of human ferritin
H, overexpression of the histone acetylase PCAF activates transcription
from the B-box of ferritin H.112 The B-box may also
mediate the increase in ferritin H mRNA that occurs during spontaneous
differentiation of Caco-2 colon carcinoma cells108 and
vascular smooth muscle.113 Other important regulatory
elements in the human ferritin H gene include a region called the A-box at position Since evaluation of the rodent cAMP regulatory region showed that
longer promoter fragments exhibited a reduced rather than enhanced
response to thyrotropin, these experiments also suggested the presence
of negative cis-acting elements that may counteract the
effect of cAMP and thyrotropin. Additional evidence for a negative
regulator(s) of ferritin H transcription was obtained by Barresi et
al.115 This group demonstrated that there is a stretch of
10 G's, which they termed "G-fer" between Thryoid hormone may also regulate ferritin posttranscriptionally: T3 modulates the activity of IRP1, affecting its ability to bind to the ferritin IRE, possibly through induction of signal transduction cascades that result in phosphorylation of IRP1.116 T3 and TRH also induce the phosphorylation of IRP2.51 Similarities between the murine and human ferritin H gene highlight the conservation not only of ferritin function, but of ferritin regulation across species. The murine ferritin H gene contains similar elements to those described above; however, they are located almost 5 kb 5' to the corresponding regulatory elements identified in the human ferritin H gene (see Figure 2). The murine ferritin H gene contains a basal enhancer FER1 that also binds p300 and is inhibited by E1A.117 Contained within FER1 is a region of dyad symmetry that binds SP1, like the A-box of the human ferritin H gene. However, to date the FER1 region has not been shown to respond to cAMP. In addition to thyroid hormone, insulin and IGF-1 have also been implicated in regulation of ferritin at the mRNA level. Insulin and IGF-1 both induced mRNA for H and L ferritin in C6 glioma cells.118 There was no additive effect on ferritin induction when both hormones were combined at the optimal concentration of each, suggesting that insulin might be acting through the IGF-1 receptor.118 In contrast to the equal induction of ferritin H and L by insulin and IGF-1, in pancreatic cells high glucose caused selective induction of ferritin H mRNA, with a 4-fold to 8-fold increase in ferritin H mRNA, a 75% to 90% decrease in ferritin L, and an overall 3-fold increase in ferritin as assayed by immunostaining.119
Among the most carefully studied areas of ferritin biology have been the changes in ferritin and other proteins of iron metabolism that occur during hematopoietic differentiation. This emphasis is appropriate for many reasons: the availability of iron during erythropoiesis is a critical aspect of mammalian homeostasis; the unique role of macrophages and monocytes in iron handling is essential to the understanding of iron recycling; and finally, the experimental systems, derived for the most part from malignant cells, provide an excellent model for studying ferritin regulation in proliferating malignant cells and their differentiated (and less malignant) counterparts. In many of these model systems ferritin H transcription is selectively induced, leading to H-rich ferritin protein over the time course of differentiation. However, some of the reports infer transcriptional activity from the changes in steady-state levels of mRNA, without either assessment of transcription rates, mRNA stability, or evaluation of transcription from heterologous promoters. It should also be noted that inducers of cellular differentiation trigger a complex process often spanning many days, and the proximal regulators of ferritin alterations observed in many of the experiments described below have often not been identified. HL60 promyelocytic cells reproducibly demonstrate a shift toward the accumulation of H-rich ferritin protein and mRNA with differentiation.120,121 In HL60 cells induced to differentiate into macrophages with the phorbol ester PMA, ferritin H mRNA levels increased up to 16-fold in 3 days; in cells induced to differentiate into neutrophils with dimethylsulfoxide (DMSO) there was a more modest 3-fold increase. In an HL60 cell line variant which produced phenotypes of intermediate differentiation, ferritin H and L were expressed at different stages of differentiation: H ferritin mRNA was expressed in the most differentiated promyelocytic cells, whereas early in the differentiation process L subunit induction was observed.122 Erythroleukemia cell lines have also been investigated extensively for their ability to express ferritin during differentiation and on exposure to hemin. Much of this work has been performed using Friend erythroleukemia cells, which are mouse erythroleukemia cells that differentiate no further along the erythropoietic lineage than proerythroblasts. In response to the differentiation inducer DMSO, a biphasic transcriptional induction of ferritin H and L mRNA was observed; however, no corresponding increase in ferritin protein synthesis was detected.123,124 Hemin increased the concentration of ferritin H mRNA 10-fold and ferritin protein 20-fold in Friend leukemia cells. Protoporphyrin IX increased ferritin H mRNA but not ferritin protein, possibly due to its iron chelation effect. Ferric ammonium citrate was a less potent inducer of both ferritin H mRNA and ferritin protein than hemin, in both Friend erythroleukemia cells125 and in fibroblasts.126 Although the differentiation inducers DMSO and hexamethylenbisacetamide (HMBA) had only a 2-fold effect on ferritin mRNA or protein synthesis when used alone as differentiation inducers, when hemin was added to these inducers, a synergistic effect on ferritin was seen. The effect was both transcriptional and translational, with ferritin H and L mRNA induction of approximately 15-fold as well as a 20-fold to 25-fold increase in ferritin protein. Desferrioxamine had no effect on ferritin mRNA accumulation. Interestingly, the induction of ferritin was not associated with a decrease in transferrin receptor expression, as might be predicted through IRP-mediated posttranscriptional mechanisms. Rather, hemin and protoporphyrin IX transcriptionally induced both ferritin H and L and transferrin receptor genes. A similar finding of induction of ferritin genes associated with an increase, not decrease, in transferrin receptor was seen in erythropoietin-induced differentiation of J2E erythroid cells.127 In murine and human erythroleukemic cells, erythropoietin treatment modulated IRP, resulting in IRP activation,128 possibly via induction of a signal transduction cascade and phosphorylation of IRP.51 Taken in aggregate, these experiments with erythroleukemia model systems show that either differentiation inducers or hemin result in a transcriptional induction of both H and L ferritin genes. It is interesting that a wide range of inducers, which can direct differentiation along different hematopoietic lineages, regulate the coordinate induction of ferritin genes. The molecular details of transcriptional regulation of human ferritin in the mouse Friend erythroleukemia system have been investigated.129 The minimum region of the ferritin H promoter that was able to confer transcriptional regulation by heme was 77 bp upstream of the TATA box. This region binds a protein complex referred to as the heme responsive factor, which was identified as NF-Y, an ubiquitous transcription factor. The CCAAT element in this region is critical, since a point mutation abolished binding to the heme responsive factor and transcriptional activation. The pathway of hemin activation was not defined, but the induction of ferritin H and L transcription proceeded in both normal and cAMP protein kinase-deficient murine erythroleukemia (MEL) cells, suggesting the cAMP pathway is not involved in this induction.130 In addition to transcriptional regulation and posttranscriptional IRP-mediated regulation, altered ferritin mRNA stability has also been documented in hematopoetic cells. Using K562 cells in which hemin was added, the level of ferritin H and L mRNA increased 2-fold to 5-fold or 2-fold to 3-fold over 24 hours, respectively, whereas the protein increased 10-fold to 30-fold. This mRNA increase was not inhibited by desferrioxamine, suggesting that it was not mediated through chelatable iron. Further, transcription assays for ferritin H and L genes were unchanged. Although mRNA stability was not directly measured, these results led to the suggestion that changes in mRNA stability explained the ferritin mRNA rise with hemin treatment.131,132 Similar conclusions were reached in the human monocytic cell line THP-1, which can be induced to differentiate into macrophages by treatment with the phorbol ester PMA; PMA treatment elicited an induction of ferritin H.133 Subsequent studies that directly investigated the stability of ferritin H mRNA found evidence that PMA stabilized ferritin H mRNA. This effect was mediated by pyrimidine-rich sequences within the 3' UTR of the ferritin gene.134
Recently, a novel mitochondrial ferritin gene has been reported.14 This intronless gene contains a mitochondrial localization signal and is expressed in the mitochondrial matrix. It exhibits more than 75% sequence identity to the ferritin H gene, and appears to sequester iron more avidly than cytosolic H-rich ferritins. Northern blot analysis revealed that expression of mitochondrial ferritin is normally restricted to testicular tissue. However, use of a specific antibody demonstrated that mitochondrial ferritin can also be expressed in erythroblasts from patients with X-linked sideroblastic anemia. Although work on this new form of ferritin is still in its early stages, these results suggest that mitochondrial ferritin may be induced under conditions of pathologic iron accumulation in heme-synthesizing cells. In another area of intense recent investigation, a novel role for ferritin H in hemoglobin switching has also been proposed. Using gel mobility shift assays in K562 erythroleukemic cells, Broyles and coworkers demonstrated specific binding of a protein with properties of ferritin H to a conserved CAGTGC motif in the beta globin promoter.135 Transient transfection assays revealed that ferritin H repressed synthesis of beta globin, suggesting that ferritin may play a role in hemoglobin switching. Although a nuclear distribution and function for ferritin has not been unequivocally documented, the accumulation of reports of nuclear ferritin localization needs careful attention,136,137 particularly given the report of an E coli protein structurally related to ferritin that binds to and protects DNA from oxidative damage.138
One of the major functions of ferritin is to limit Fe(II) available to participate in the generation of oxygen free radicals (ROS). Oxidant stress is an ever-present threat to organismal survival, both from exogenous and endogenous cellular sources; it is therefore not surprising that oxidant stress activates multiple pathways of ferritin regulation. How these pathways interact is just beginning to be understood, as is the role of ferritin in the substantial cassette of gene and protein alterations that coordinately limit oxidant toxicity. There is strong experimental support for ferritin as a protectant against oxidant stress. Early studies demonstrated that exposure to heme induced ferritin synthesis in endothelial cells and concordantly reduced their cytotoxic response to hydrogen peroxide.139 In tumor cell lines, sensitivity to oxidants was inversely correlated with ferritin protein levels; modulation of ferritin levels with hemin could alter oxidant sensitivity.140 These results are consistent with more recent observations that increased ferritin levels reduce the low molecular weight ("labile" or "regulatory") iron pool.30 They are also consistent with observations that a reduction in ferritin sensitizes cells to pro-oxidant cytotoxicity,141 that overexpression of ferritin reduces oxidant species in cells challenged with oxidants142,143 and reduces oxidant toxicity,144 as well as the importance of ferritin H ferroxidase activity142 in limiting oxidant toxicity. Both transcriptional and posttranscriptional mechanisms have been implicated in ferritin induction by oxidants. Oxidants induce ferritin transcription by directly targeting conserved regions of ferritin genes.145 Transcriptional induction of ferritin H and L genes was also observed in rat livers after injection with phorone, which reduces glutathione concentration and therefore limits free radical defense mechanisms.146 Oxidative stress can also contribute to ferritin induction by inactivating IRP1 through reversible oxidation of critical cysteine residues.147 However, oxidant-mediated inactivation of IRP1 is not always seen. In fact, in other experimental systems, oxidants had the opposite effect: hydrogen peroxide activated the iron responsive protein (IRP1), possibly through induction of a signaling pathway that mobilizes iron from the 4Fe-4S cubane cluster.148 This results in reduced ferritin synthesis posttranscriptionally, potentially leaving the cell more susceptible to oxidative injury.149 These observations are difficult to reconcile with a postulated role for ferritin in the protection against oxidative stress. Recent work has offered a model that permits observations regarding IRP
activation, ferritin induction, and the protection from oxidative
stress to be resolved. In cultured BNLCL2 mouse liver cells following
acute oxidant challenge, IRP was activated only transiently, and thus
ferritin translation was only transiently inhibited. At the same time,
a sustained increase in ferritin transcription was induced. The
ultimate result was an increase in ferritin protein in oxidant-treated
cells, a condition that permits reduction in oxidant-induced cell
injury.143,145 These results emphasize that
transcriptional and translational controls collaborate in the
determination of ultimate cellular ferritin content (see Figure
3).
Oxidants may also alter ferritin transcription and translation through release of iron from cellular proteins. Oxidants, including ROS86,146,150 and nitric oxide,151 may release iron from ferritin, IRP1, or hemoglobin,152 either directly or through heme oxygenase (in the case of heme-containing proteins).39 This can lead to ferritin induction through IRP inhibition (above), and perhaps through direct iron-mediated transcriptional regulation of ferritin.153,154 Assessment of alterations in cellular iron due to breakdown of ferritin, aconitase iron clusters, heme-containing proteins, and other proteins will be immeasurably aided by recently described methods to directly measure a "labile" iron pool.31 Although much experimental work has centered on hydrogen
peroxide-mediated generation of ROS, other forms of oxidant stress also alter ferritin. For example, UV irradiation, which produces oxygen-free radicals and damages DNA, induced ferritin H mRNA, and
protein.155,156 Menadione, a synthetic vitamin K
derivative, and its water soluble form, menadione sodium bisulfite,
were shown to induce ferritin in the rat liver, an effect which was
preceded by heme oxygenase induction, as well as hydrogen peroxide
generation and changes in the intrahepatic GSH pool. Menadione sodium
bisulfite was also shown to decrease both IRP1 and aconitase activity
in B6 fibroblasts.157 Another oxidant, oxidized
lipoproteins, dramatically stimulated ferritin L in the THP-1
macrophage line.158 Various components of oxidized LDL
were able to recapitulate this response, which may be mediated by
peroxisome proliferator-activated receptor
|